How should we address non-reproducibility?
Philosophical Transactions B · 19.03.2026 · 381 (1946)
DOI: 10.1098/rstb.2025.0057 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Philosophical Transactions B, online erschienen am 19.03.2026. Verfasst von Torben Göpel. Beteiligte Einrichtung: Multiscale Biology, Johann-Friedrich-Blumenbach-Institut für Zoologie and Anthropologie, Georg-August-Universität Göttingen, Göttingen, Niedersachsen…. Hauptthemen laut MEDLINE: Research Design. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft, Alexander von Humboldt-Stiftung.
Abstract (Originalsprache)
Inter-experimental variability poses a significant challenge to reproducibility in experimental biology, hindering scientific progress and the translation of research findings. This variability arises from numerous factors, including subtle differences in reagents, equipment calibration, environmental conditions and unaccounted biological variation. Despite the existence of guidelines such as ARRIVE (Animal Research: Reporting of In Vivo Experiments) and MDAR (Materials Design Analysis Reporting), the reporting of crucial experimental details often remains incomplete or inconsistent across studies. Recent analyses have suggested that the insufficient reporting of materials and methods may substantially contribute to non-reproducibility in biological research. This underscores the need for more comprehensive and standardized reporting practices as the best approach to ensure good science. To address this issue, publishers, editors and reviewers must enforce existing standards more rigourously, while authors and researchers should prioritize the comprehensive reporting of experimental details. Innovative approaches such as experimental heterogenization and open science initiatives are emerging to enhance reproducibility. A multifaceted approach involving stricter guideline enforcement, recognition of replication studies and fostering a culture that values reproducibility over publication speed and sensationalization is essential for improving the reliability and credibility of experimental biology research. This article is part of the theme issue ‘Embracing variability in comparative physiology: why it matters and what to do with it’.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Multiscale Biology, Johann-Friedrich-Blumenbach-Institut für Zoologie and Anthropologie, Georg-August-Universität Göttingen, Göttingen, Niedersachsen, Germany.
- Department of Biological Sciences, University of North Texas, Denton, TX, USA.
ORCID-Profile: Torben Göpel
Förderung
- Deutsche Forschungsgemeinschaft
- Alexander von Humboldt-Stiftung
Zitieren
APA
Göpel, T. (2026). How should we address non-reproducibility?. Philosophical Transactions B, 381(1946). https://doi.org/10.1098/rstb.2025.0057
Vancouver
Göpel T. How should we address non-reproducibility?. Philosophical Transactions B. 2026;381(1946). doi:10.1098/rstb.2025.0057
BibTeX
@article{Gpel2026,
author = {Göpel, Torben},
title = {How should we address non-reproducibility?},
journal = {Philosophical Transactions B},
year = {2026},
volume = {381},
number = {1946},
doi = {10.1098/rstb.2025.0057}
}
EUVIMED